You have 9 free searches left this month | for more free features.

E-602

Showing 1 - 25 of 4,666

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

Coronary Artery Disease Trial in Korea, Republic of (Prasugrel 5mg, Ticagrelor 60mg)

Recruiting
  • Coronary Artery Disease
  • Prasugrel 5mg
  • Ticagrelor 60mg
  • Changwon, Gyeongsangnam-do, Korea, Republic of
  • +7 more
Jan 28, 2021

Transfusional Iron Overload, Beta-Thalassemia Trial in Worldwide (SPD602)

Terminated
  • Transfusional Iron Overload
  • Beta-Thalassemia
  • Boston, Massachusetts
  • +8 more
Jun 10, 2021

Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (SPD602)

Terminated
  • Iron Overload Due to Repeated Red Blood Cell Transfusions
  • Los Angeles, California
  • +11 more
Jun 11, 2021

Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (E7050, Cetuximab)

Completed
  • Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
  • Tucson, Arizona
  • +22 more
Dec 3, 2021

Endometriosis Trial in Japan (Dydrogesterone)

Completed
  • Endometriosis
  • Tokyo, Chiyodaku, Japan
  • +14 more
Jun 13, 2022

Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Brussels, Belgium
  • +30 more
Aug 9, 2022

Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)

Terminated
  • Acute Myeloid Leukemia
  • Myeloid Dysplastic Syndrome
  • Buffalo, New York
  • +20 more
Jan 21, 2022

Achondroplasia Trial in Worldwide (Recifercept)

Recruiting
  • Achondroplasia
  • Recifercept
  • Irvine, California
  • +12 more
Jul 28, 2022

Achondroplasia Trial in Worldwide (Recifercept)

Recruiting
  • Achondroplasia
  • Recifercept
  • Aliso Viejo, California
  • +13 more
Aug 3, 2022

Transfusional Iron Overload, Beta-thalassemia Trial in Worldwide (SPD602 (FBS0701, SSP-004184))

Completed
  • Transfusional Iron Overload
  • Beta-thalassemia
  • SPD602 (FBS0701, SSP-004184)
  • Oakland, California
  • +8 more
May 30, 2021

Pancreatic Tumors Trial in Worldwide (BAY86-9766+Gemcitabine)

Completed
  • Pancreatic Neoplasms
  • Aurora, Colorado
  • +22 more
Apr 6, 2021

Erosive Esophagitis Trial in Worldwide (Dexlansoprazole)

Not yet recruiting
  • Erosive Esophagitis
  • Mobile, Alabama
  • +44 more
Jun 13, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +23 more
Aug 1, 2022

Asthma Trial in Worldwide (Dupilumab, Placebo)

Recruiting
  • Asthma
  • Cullman, Alabama
  • +37 more
Mar 29, 2022

The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study

Recruiting
  • Hearing Loss
  • +5 more
  • Bone Conduction Implant
  • Innsbruck, Austria
  • +7 more
Jan 21, 2022

Hidradenitis Suppurativa (HS) Trial in Worldwide (Upadacitinib, Placebo Upadacitinib)

Completed
  • Hidradenitis Suppurativa (HS)
  • Phoenix, Arizona
  • +25 more
Mar 22, 2022

Psoriasis Trial in Worldwide (M1095 (Sonelokimab), Placebo, Secukinumab)

Completed
  • Psoriasis
  • M1095 (Sonelokimab)
  • +2 more
  • Birmingham, Alabama
  • +59 more
Aug 2, 2021

HBV, Chronic HBV Infection Trial in Worldwide (TAF, TDF, TAF Placebo)

Active, not recruiting
  • HBV
  • Chronic HBV Infection
  • Los Angeles, California
  • +159 more
Mar 17, 2022

Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Lutikizumab
  • Placebo
  • Phoenix, Arizona
  • +53 more
Aug 15, 2022

Chronic Spontaneous Urticaria Trial in Worldwide (rilzabrutinib, )

Recruiting
  • Chronic Spontaneous Urticaria
  • Caba, Buenos Aires, Argentina
  • +48 more
Aug 3, 2022

Hemophilia A, Hemophilia B Trial in Worldwide (fitusiran, factor concentrates)

Completed
  • Hemophilia A
  • Hemophilia B
  • Little Rock, Arkansas
  • +63 more
Mar 15, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Woolloongabba, Queensland, Australia
  • +94 more
Aug 17, 2022

Psoriasis Trial in Worldwide (BMS-986165, Placebo for BMS-986165)

Completed
  • Psoriasis
  • Irvine, California
  • +75 more
Oct 30, 2020

Palmoplantar Pustulosis Trial in Worldwide (Spesolimab)

Recruiting
  • Palmoplantar Pustulosis
  • Birmingham, Alabama
  • +65 more
Aug 9, 2022